302 results
-
List item
Human medicine European public assessment report (EPAR): Pioglitazone Teva (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012,
, Revision: 11, Authorised, Last updated: 01/03/2021
Pioglitazone Teva Diabetes Mellitus … Authorised pioglitazone Overview This is a summary … assessment report (EPAR) for Pioglitazone Teva. It explains how the … -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Accord (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 21/03/2012,, Revision: 6, Authorised, Last updated: 26/02/2021
Pioglitazone Accord Diabetes Mellitus … Pioglitazone Accord … Pioglitazone Accord, INN Pioglitazone hydrochloride 30 Churchill … -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Actavis
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/03/2012,, Revision: 7, Authorised, Last updated: 16/09/2020
Pioglitazone Actavis Diabetes Mellitus … Pioglitazone Actavis … Pioglitazone Actavis, INN pioglitazone 30 Churchill Place … -
List item
Withdrawn application: Pioglitazone ratio
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratio: Withdrawn application … initial authorisation) Pioglitazone ratio pioglitazone On 21 July 2011 the Committee … for the medicinal product Pioglitazone ratio 15, 30, 45 mg tablet … -
List item
Withdrawn application: Pioglitazone ratiopharm
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratiopharm: Withdrawn applica … initial authorisation) Pioglitazone ratiopharm pioglitazone On 21 July 2011 the Committee … for the medicinal product Pioglitazone ratiopharm 15, 30, 45 mg … -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Krka
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 21/03/2012,, Revision: 2, Withdrawn, Last updated: 26/09/2014
Pioglitazone Krka Diabetes Mellitus … Pioglitazone Krka … Pioglitazone Krka, INN pioglitazone 30 Churchill Place … -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Teva Pharma
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012,, Revision: 11, Authorised, Last updated: 21/07/2020
Pioglitazone Teva Pharma Diabetes Mellitus … Pioglitazone Teva Pharma … summary for the public Pioglitazone Teva Pharma pioglitazone This is a summary of the … -
List item
Withdrawn application: Pioglitazone Teva Generics
pioglitazone, date of withdrawal: 26/01/2012, Initial authorisation, Last updated: 03/07/2012Pioglitazone Teva Generics: Withdrawn … initial authorisation) Pioglitazone Teva Generics pioglitazone On 22 September 2011 the … for the medicinal product Pioglitazone Teva Generics 15, 30, 45 … -
List item
Withdrawn application: Pioglitazone ratiopharm GmbH
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratiopharm GmbH: Withdrawn … initial authorisation) Pioglitazone ratiopharm GmbH pioglitazone On 21 July 2011 the Committee … for the medicinal product Pioglitazone ratiopharm GmbH 15, 30, 45 … -
List item
Human medicine European public assessment report (EPAR): Glidipion (previously Pioglitazone Actavis Group)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/03/2012,, Revision: 7, Authorised, Last updated: 20/07/2020
Glidipion (previously Pioglitazone Actavis Group) Diabetes … Glidipion (previously Pioglitazone Actavis Group … for the public Glidipion Pioglitazone This is a summary of the … -
List item
Human medicine European public assessment report (EPAR): Glustin (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 11/10/2000, Revision: 26, Authorised, Last updated: 02/03/2021Authorised pioglitazone Overview This is a summary … medicine. active substance pioglitazone. It is available as white … active substance in Glustin, pioglitazone, makes cells (fat, muscle … -
List item
Human medicine European public assessment report (EPAR): Actos (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 13/10/2000, Revision: 27, Authorised, Last updated: 04/03/2021Authorised pioglitazone Overview This is a summary … medicine. active substance pioglitazone. It is available as tablets … active substance in Actos, pioglitazone, makes cells (fat, muscle … -
List item
Human medicine European public assessment report (EPAR): Paglitaz
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 21/03/2012,, Revision: 1, Withdrawn, Last updated: 10/03/2016
pioglitazone … authorisation of Paglitaz (pioglitazone) ceased to be valid in the … for the public Paglitaz pioglitazone This is a summary of the … -
List item
Human medicine European public assessment report (EPAR): Sepioglin
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 09/03/2012,, Revision: 1, Withdrawn, Last updated: 18/07/2013
pioglitazone … medicinal product Sepioglin, (pioglitazone), which had been approved … for the public Sepioglin pioglitazone This is a summary of the … -
List item
Human medicine European public assessment report (EPAR): Tandemact (updated)
pioglitazone, glimepiride, Diabetes Mellitus, Type 2
Date of authorisation: 08/01/2007, Revision: 18, Authorised, Last updated: 02/03/2021Authorised pioglitazoneglimepiride Overview This is a summary … medicine. active substances , pioglitazone and glimepiride. It is available … available as tablets (30 mg pioglitazone and 2 or 4 mg glimepiride … -
List item
Human medicine European public assessment report (EPAR): Incresync
alogliptin, pioglitazone, Diabetes Mellitus, Type 2
Date of authorisation: 19/09/2013, Revision: 8, Authorised, Last updated: 18/12/2020alogliptin / pioglitazone … Incresync alogliptin / pioglitazone This is a summary of the … substances alogliptin and pioglitazone. It is used as an addition … -
List item
Human medicine European public assessment report (EPAR): Glubrava (updated)
metformin hydrochloride, pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 11/12/2007, Revision: 17, Authorised, Last updated: 04/03/2021Authorised pioglitazonemetformin Overview This is a summary … medicine. active substances , pioglitazone (15 mg) and metformin hydrochloride … Glubrava may need to introduce pioglitazone slowly until a dose of 30 … -
List item
Human medicine European public assessment report (EPAR): Competact (updated)
pioglitazone, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 28/07/2006, Revision: 18, Authorised, Last updated: 04/03/2021Authorised pioglitazonemetformin Overview This is a summary … medicine. active substances , pioglitazone (15 mg) and metformin hydrochloride … need to slowly introduce pioglitazone until a dose of 30 mg per … -
List item
Orphan designation: pioglitazone for: Treatment of adrenoleukodystrophy
Date of first decision: 19/02/2014, Positive, Last updated: 02/04/2014Therapeutics S.L., Spain, for pioglitazone for the treatment of adrenoleukodystrophy … medicine expected to work? Pioglitazone is a medicine that has been … cells including nerve cells. Pioglitazone is expected to protect nerve … -
List item
Orphan designation: pioglitazone hydrochloride for: Treatment of sudden sensorineural hearing loss
Date of first decision: 12/01/2017, Positive, Last updated: 11/07/2017Regiomedica GmbH, Germany, for pioglitazone hydrochloride for the treatment … information to show that pioglitazone hydrochloride might be of … expected to work? The way pioglitazone hydrochloride works in SSNHL … -
List item
Referral: Metformin and metformin-containing medicines
metformin, associated names: Xigduo, Vipdomet, Velmetia, Synjardy, Ristfor, Komboglyze, Jentadueto, Janumet, Icandra (previously Vildagliptin / metformin hydrochloride Novartis), Glubrava, Eucreas, Efficib, Ebymect, Competact, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/10/2016, EC decision date: 12/12/2016, Last updated: 21/12/2016hydrochloride sitagliptin metformin vildagliptin metformin pioglitazone metformin vildagliptin met … n dapagliflozin metformin pioglitazone metformin metformin hydrochloride dapagliflozin … hydrochloride metformin hydrochloride pioglitazone hydrochloride vildagliptin metformin … -
List item
Press release: EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU
Last updated: 15/10/2018under increased supervision; Aurobindo Pharma stopped from supplying … under increased supervision; Aurobindo Pharma stopped from supplying … -
List item
Press release: Update on ongoing European review of pioglitazone–containing medicines
CHMP, Last updated: 09/06/2011ongoing European review of pioglitazone–containing medicines … ongoing European review of pioglitazone–containing medicines … ongoing European review of pioglitazone– containing medicines Suspension … -
List item
Press release: European Medicines Agency updates on ongoing benefit-risk review of pioglitazone–containing medicines
CHMP, Last updated: 23/06/2011ongoing benefit-risk review of pioglitazone–containing medicines … ongoing benefit-risk review of pioglitazone–containing medicines … ongoing benefit-risk review of pioglitazone–containing medicines 7 Westferry … -
List item
Press release: Merck Sharp & Dohme (Europe), Inc. withdraws its marketing authorisation application for Janacti (sitagliptin and pioglitazone) and related trade names
Last updated: 14/11/2011Janacti (sitagliptin and pioglitazone) and related trade names … Janacti (sitagliptin and pioglitazone) and related trade names … Janacti (sitagliptin and pioglitazone) and related trade names …